Mimetas Contract - Development of 3D Human Blood Brain Barrier Formation Assay (

This contract involves external research support to develop a novel assay focused on the formation of a three-dimensional human blood-brain barrier, which aligns with the High Funding Priority (HFP) research area targeting developmental neurotoxicity. The contract is being managed by the Food and Drug Administration, specifically aimed at advancing scientific methods for better understanding and assessing neurotoxic effects during development. The contract falls under the NAICS code 541990, indicating it is related to specialized scientific research and development services. While specific details such as the solicitation number, office location, and contracting officer information are pending, the primary point of contact for program-related inquiries is the HFP Acquisition Liaison. This effort is positioned as a forward-looking forecast opportunity, emphasizing innovation in biomedical research tools relevant to neurotoxicity and human health risk assessment.